Skip to content
Low DoseGLP-1Providers

A closer look at low-dose care

Low-dose GLP-1.
The full picture.

Compare 548 providers, understand what a lower dose actually costs, and explore what the evidence supports. Clear prices. Considered reviews. Room for uncertainty.

Intentional microdosing is off-label and unproven. A lower dose does not guarantee a lower bill or fewer risks.

providers tracked
548providers tracked
provider reviews
548provider reviews
research guides
90research guides

Featured partner

$149–$199/mo microdose ($99–$149 standard)

CoreAge Rx

Two named microdosing programs with their own monthly prices, sold beside standard plans that cost less. It sells a named microdose program at a flat monthly price, with no membership or lab fee underneath it. It sits at the top of our boards because it is our featured partner, not because of a score — and nothing here is a promise of results.

We earn a commission if you start care through some of these links, at no extra cost to you. Affiliate partners are listed first on our ranked boards; every provider gets the same write-up and the same button. See our disclosure.

Also worth comparing

  • FoundPartner

    From $169/mo on 12-mo prepay · $289/mo month to month · Long-running physician-led weight care with a GLP-1 microdosing program, priced flat at every dose on cash or insurance plans.

    Visit site
  • Gala HealthPartner

    $199/mo on 3-mo plan · from $129 sema, $179 tirz · Compounded semaglutide and tirzepatide for women in all 50 states, one price at every dose, with no microdose tier on its public pages.

    Visit site

Microdosing is off-label and unproven — decide with a clinician.

From the evidence hub

All 90 →

Our evidence articles trace each conclusion to primary research or official labeling, including null results; provider reviews are written from each company's own published pages and prices. Some providers on the ranking pay us a commission, at no extra cost to you, and partners are listed first — we say so on the ranking itself. Read how we research and rank in our editorial policy.